Gamida Cell Ltd.
NASDAQ:GMDA
0.03 (USD) • At close September 17, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Gamida Cell Ltd. |
Symbool | GMDA |
Munteenheid | USD |
Prijs | 0.033 |
Beurswaarde | 4,337,295 |
Dividendpercentage | 0% |
52-weken bereik | 0.03 - 2.51 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Ms. Abigail L. Jenkins |
Website | https://www.gamida-cell.com |
An error occurred while fetching data.
Over Gamida Cell Ltd.
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials in
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)